LncRNA FRMD6-AS2 inhibits the malignant progression of bladder cancer by targeting miR-1260a. Dai P, Chen L, Dong Z, Wang H, et al. World J Surg Oncol 2026 Jan 7. doi: 10.1186/s12957-025-04171.

Read + Share

Amedeo Smart

Independent Medical Education

Dai P, Chen L, Dong Z, Wang H, et al. LncRNA FRMD6-AS2 inhibits the malignant progression of bladder cancer by targeting miR-1260a. World J Surg Oncol 2026 Jan 7. doi: 10.1186/s12957-025-04171.
PMID: 41501842